Many of the present generation biomaterials are still based upon the early
concept that implantable materials should be bioinert and therefore designe
d to evoke minimal tissue response, if none. However, a growing body of cli
nical data demonstrates that the long survivability of these materials is h
ampered by high rates of failure, which is primarily attributed to interfac
ial instability. It has therefore become understood that this approach is n
ot optimal. Modern approaches implicate the use of biomaterials that can ac
tively interact with tissues and induce their intrinsic repair and regenera
tive potential. This involves control over the cell cycle, the molecular fr
amework that controls cell proliferation and differentiation. Class A bioac
tive glass-ceramic materials were the first materials shown to endorse thes
e properties and, depending upon the rate of resorption and release of ions
, can create chemical gradients with specific biological actions over cells
and tissues. Optimising this bioactive regenerative capacity of Bioactive
glass-ceramics offers great hope for producing biomaterials that can stimul
ate growth, repair, and regeneration of any human tissue.